Drug recall · October 22, 2025
Hydromorphone HCL PF recall
Why: Labeling: Incorrect or Missing Lot and/or Exp Date
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
- Lots / codes
Lot #: 25104595A, Expiry: 27DEC2025.
- Company
- STAQ Pharma, Inc., Denver, CO
- Distribution
- Nationwide in the U.S.
- Initiated
- October 9, 2025 · Voluntary: Firm initiated
- Classified
- October 15, 2025
- Reported
- October 22, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydromorphone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.